Details for Patent: 9,259,428
✉ Email this page to a colleague
Summary for Patent: 9,259,428
Title: | Combination of azelastine and fluticasone for nasal administration |
Abstract: | A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration. |
Inventor(s): | Lulla; Amar (Mumbai, IN), Malhotra; Geena (Mumbai, IN) |
Assignee: | Cipla Limited (Mumbai, IN) |
Application Number: | 14/661,720 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,259,428 |
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 9,259,428
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,259,428
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 428428 | ⤷ Try a Trial | |||
Australia | 2003244799 | ⤷ Try a Trial | |||
Australia | 2009243420 | ⤷ Try a Trial | |||
Australia | 2009243422 | ⤷ Try a Trial | |||
Brazil | 0312128 | ⤷ Try a Trial | |||
Brazil | 122014030154 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |